Mrp2 is essential for estradiol-17β(β-D-glucuronide)-induced cholestasis in rats

Hepatology

Volumn 32, Issue 1, 2000, Pages 66-72

  Huang, Liyue ^a   Smit, Johan W ^b   Meijer, Dirk K F ^c   Vore, Mary ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

^b NETHERLANDS CANCER INSTITUTE   (Netherlands)

^c UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL 17 GLUCURONIDE; MULTIDRUG RESISTANCE PROTEIN; TAUROCHOLIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BILE FLOW; CHOLESTASIS; CONTROLLED STUDY; MEMBRANE TRANSPORT; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RAT;

EID: 0034234705     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhep.2000.8263     Document Type: Article

References (26)

1. 1. Trauner M, Meier PJ, Boyer JL. Molecular pathogenesis of cholestasis. N Engl J Med 1998;339:1217-1227.
2. 2. Thiebaut F, Tsuruo T, Hamada H, Gottesman MM, Pastan I, Willingham MC. Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues. Proc Natl Acad Sci U S A 1987;84:7735-7738.
3. 3. Gottesman MM, Pastan I. Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu Rev Biochem 1993;63:385-472.
4. 4. Huang L, Hoffman T, Vore M. Adenosine triphosphate-dependent transport of estradiol-17β(β-D-glucuronide) in membrane vesicles by MDR1 expressed in insect cells. HEPATOLOGY 1998;28:1371-1377.
5. 5. Oude Elferink RPJ, Tytgat, GNJ, Groen AK. Hepatic canalicular membrane 1. The role of mdr2 P-glycoprotein in hepatobiliary lipid transport. FASEB J 1997;11:19-28.
6. 6. Oude Elferink RPJ, Meijer DKF, Kuipers F, Jansen PLM Groen AK, Groothuis GMM. Hepatobiliary secretion of organic compounds: molecular mechanisms of membrane transport. Biochim Biophys Acta 1995;1241: 215-268.
7. 7. Keppler D, Konig J. Hepatic canalicular membrane 5: expression and localization of the conjugate export pump encoded by the MRP2 (cMRP/ cMOAT) gene in liver. FASEB J 1997;11:509-516.
8. 8. Child S, Yeh RL, Georges E, Ling V. Identification of a sister gene to P-glycoprotein. Cancer Res 1995;55:2029-2034.
9. 9. Gerloff T, Stieger B, Hagenbuch B, Madon J, Landmann L, Roth J, Hofmann AF, et al. The sister of P-glycoprotein represents the canalicular bile salt export pump of mammalian liver. J Biol Chem 1998;273:10046-10050.
10. 10. Nathanson MH, Boyer JL. Mechanisms and regulation of bile secretion. HEPATOLOGY 1991;14:551-566.
11. 11. Vore M, Slikker W. Steroid D-ring glucuronides: a new class of cholestatic agents. Trends Pharmacol Sci 1985;6:256-259.
12. 12. Durham S, Vore M. Taurocholate and steroid glucuronides: mutual protection against cholestasis in the isolated perfused rat liver. J Pharmacol Exp Ther 1986;237:490-495.
13. 3H] estradiol-17β-(β-D-glucuronide) binding sites in basolateral and canalicular liver plasma membranes. Biochem Pharmacol 1990;40:1219-1225.
14. 14. Liu Y, Huang L, Hoffman T, Gosland M, Vore M. MDR1 substrates/ modulators protect against β-estradiol-17β-D-glucuronide cholestasis in rat liver. Cancer Res 1996;56:4992-4997.
15. 15. Sano N, Takikawa H, Yamanaka M. Estradiol-17β-glucuronide-induced cholestasis - effects of ursodeoxycholate-3-O-glucuronide and 3,7-disulfate. J Hepatol 1993;7:241-246.
16. 16. Vore M, Liu Y, Huang L. Cholestatic properties and hepatic transport of steroid glucuronides. Drug Metab Rev 1997;29:183-203.
17. 17. Meier PJ, Boyer JL. Preparation of basolateral (sinusoidal) and canalicular plasma membrane vesicles for the study of hepatic transport processes. Methods Enzymol 1990;192:534-545.
18. 18. Sparreboom A, van Asperen J, Mayer U, Schinkel AH, Smit JW, Meijer DKF, Borst P, et al. Limited oral bioavailability and active epithelial excretion of paclitaxel (taxol) caused by P-glycoprotein in the intestine. Proc Natl Acad Sci U S A 1997;94:2031-2035.
19. 19. Jonker JW, Wagenaar E, van Deemter L, Gotschlich R, Bender HM, Dasenbrock J, Schinkel AH. Role of blood-brain barrier P-glycoprotein in limiting brain accumulation and sedative side-effects of asimadoline, a peripherally acting analgesic drug. Br J Pharmacol 1999;127:43-50.
20. 20. Brock WJ, Vore M. Characterization of uptake of steroid glucuronides into isolated male and female rat hepatocytes. J Pharmacol Exp Ther 1984;219:175-181.
21. 21. Stieger B, Fattinger K, Madon J, Kullak-Ublick GA, Meier PJ. Drug- and estrogen-induced cholestasis through inhibition of the hepatocellular bile salt export pump (Bsep) of rat liver. Gastroenterology 2000;118:422-430.
22. 22. Oude Elferink RPJ, Ottenhoff R, Liefting W, de Haan J, Jansen PLM. Hepatobiliary transport of glutathione and glutathione conjugate in rats with hereditary hyperbilirubinemia. J Clin Invest 1989;84:476-483.
23. 23. Meyers M, Slikker W, Pascoe G, Vore M. Characterization of cholestasis induced by estradiol-17β-D-glucuronide in the rat. J Pharmacol Exp Ther 1980;214:87-93.
24. 24. Zaman G, Lankelma J, van Telligen O, Beijnen J, Dekker H, Paulusma C, Oude Elferink RP et al. Role of glutathione in the export of compounds from cells by the multidrug-resistance-associated protein. Proc Natl Acad Sci U S A 1995;92:7690-7694.
25. 25. Vonk RJ, Danhof M, Coenraads T, Van Doorn ABD, Keulemans K, Scaf AHJ, Meijer DKF. Influence of bile salts on hepatic transport of dibromosulphthalein. Am J Physiol 1979;237:E524-534.
26. 26. Gibson GE, Forker EL. Canalicular bile flow and bromosulfophthalein transport maximum: the effect of a bile salt-independent choleretic. Gastroenterology 1974;66:1046-1053.